An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

INVOKAMET®

Drug Information Related Patent
Hold Company
JANSSEN PHARMS
Learn More
Dosage and Administration
TABLET;ORAL
Specification
50MG;500MG
50MG;1GM
150MG;500MG
150MG;1GM
Indication
INVOKAMET® can be used as diet and exercise of auxiliary means to improve glycemic control in adults with type 2 diabetes.
Use
Instructions for Use
API
CANAGLIFLOZIN
METFORMIN HYDROCHLORIDE
API Structure
We Supply
CANAGLIFLOZIN
Note:

In-house Standard
Facility GMP
CDE/USMF

METFORMIN HYDROCHLORIDE
Note:

CP/BP/EP/JP/USP
Facility GMP
Product GMP
ASMF/USMF/US-FDA/KFDA/WHO/CEP/KDMF

null
Note:

null

Drug Patent
Patent NoExpiration Date
115768942030/7/6
79435822029/2/26
79437882027/7/14
82222192025/4/11
85132022027/12/3
87854032024/7/30
API Patent
Patent NoExpiration Date
115768942030/7/6
79435822029/2/26
79437882027/7/14
82222192025/4/11
85132022027/12/3
87854032024/7/30

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top